1. Home
  2. EXEL vs AG Comparison

EXEL vs AG Comparison

Compare EXEL & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exelixis Inc.

EXEL

Exelixis Inc.

HOLD

Current Price

$52.70

Market Cap

11.4B

Sector

Health Care

ML Signal

HOLD

Logo First Majestic Silver Corp. (Canada)

AG

First Majestic Silver Corp. (Canada)

HOLD

Current Price

$16.90

Market Cap

10.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXEL
AG
Founded
1994
1979
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
11.4B
10.8B
IPO Year
2000
2004

Fundamental Metrics

Financial Performance
Metric
EXEL
AG
Price
$52.70
$16.90
Analyst Decision
Buy
Strong Buy
Analyst Count
21
3
Target Price
$46.50
$21.92
AVG Volume (30 Days)
2.4M
11.7M
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
0.12%
EPS Growth
57.95
N/A
EPS
0.79
N/A
Revenue
$452,477,000.00
N/A
Revenue This Year
$13.61
$24.41
Revenue Next Year
$13.13
$10.68
P/E Ratio
$66.50
$143.01
Revenue Growth
N/A
N/A
52 Week Low
$33.76
$7.74
52 Week High
$52.96
$32.00

Technical Indicators

Market Signals
Indicator
EXEL
AG
Relative Strength Index (RSI) 63.95 33.76
Support Level $40.17 $15.54
Resistance Level N/A $17.37
Average True Range (ATR) 1.49 1.09
MACD 0.07 -0.24
Stochastic Oscillator 96.00 0.80

Price Performance

Historical Comparison
EXEL
AG

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About AG First Majestic Silver Corp. (Canada)

First Majestic Silver Corp is in the business of production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. The company owns four producing mines in Mexico, consisting of the Santa Elena Silver/Gold Mine, the San Dimas Silver/Gold Mine, the Los Gatos Silver Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA. Additionally, the firm holds interests in the San Martin Silver Mine and the Del Toro Silver Mine, and several exploration-stage projects. The majority of the company's revenues are from the sale of precious metals contained in dore and concentrate form. It generates maximum revenue from the sale of silver, followed by gold, zinc, copper, and other metals.

Share on Social Networks: